Dalpiciclib, Fulvestrant, Trastuzumab and Pertuzumab in HR Positive, HER2 Positive Metastatic Breast Cancer
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Dalpiciclib|DRUG: Fulvestrant|DRUG: Pertuzumab|DRUG: Trastuzumab
Sponsor: Fudan University